Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract.

Hepatocyte paraffin 1 (Hep Par 1) is a monoclonal antibody considered almost specific for normal and neoplastic hepatocytes, that can be used on formalin-fixed paraffin-embedded tissues. Hep Par 1 reactivity has been demonstrated consistently in hepatocellular carcinomas and hepatoblastomas but only rarely in cholangiocarcinomas and metastatic tumors to the liver. Although its role as a marker of hepatocytic differentiation in primary liver tumors has been studied extensively, Hep Par 1 expression has not been explored in extrahepatic lesions, especially rare adenocarcinomas with hepatoid morphologic features. We studied 7 hepatoid adenocarcinomas of the gastrointestinal tract (6 gastric and 1 from the gallbladder) for Hep Par 1 immunoreactivity. Focal Hep Par 1 expression was seen in 6 of 7 tumors. These hepatoid adenocarcinomas also showed reactivity for alpha-fetoprotein and carcinoembryonic antigen. The presence of Hep Par 1 reactivity in extrahepatic hepatoid adenocarcinomas underscores the fact that Hep Par 1 expression is not unique to primary hepatocellular neoplasms. Adenocarcinomas with hepatoid features must be considered in the differential diagnosis of Hep Par 1-positive lesions.

[1]  K. Ishak,et al.  Clear Cell Carcinoma of the Liver: A Comparative Immunohistochemical Study with Renal Clear Cell Carcinoma , 2000, Modern Pathology.

[2]  L. Sobin,et al.  K‐ras and p53 mutations in the pathogenesis of classical and goblet cell carcinoids of the appendix , 1999, Cancer.

[3]  N. Theise,et al.  Immunohistochemical evaluation of hepatoblastomas with use of the hepatocyte-specific marker, hepatocyte paraffin 1, and the polyclonal anti-carcinoembryonic antigen. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[4]  R. Sormunen,et al.  Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma , 1998, Histopathology.

[5]  K. Batts,et al.  Carcinoma of the stomach with hepatocyte differentiation (hepatoid adenocarcinoma). , 1997, Mayo Clinic proceedings.

[6]  E. Lerma,et al.  Clear cell tumors of the female genital tract. , 1997, Seminars in diagnostic pathology.

[7]  T. Yoshiki,et al.  Gastrointestinal hepatoid adenocarcinoma: venous permeation and mimicry of hepatocellular carcinoma, a report of four cases , 1997, Histopathology.

[8]  Randall G. Lee,et al.  Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[9]  D. Henson,et al.  Unusual malignant epithelial tumors of the gallbladder. , 1996, Seminars in diagnostic pathology.

[10]  H. Ishikura,et al.  Alpha-fetoprotein production by a hepatoid adenocarcinoma of the uterus. , 1996, Journal of clinical pathology.

[11]  A. Östör,et al.  Alpha‐fetoprotein‐producing adenocarcinoma of the sigmoid colon with possible hepatoid differentiation , 1995, Pathology.

[12]  J. Albores–Saavedra,et al.  Clear cell carcinomas of the gallbladder and extrahepatic bile ducts. , 1995, The American journal of surgical pathology.

[13]  T. Motoyama,et al.  Different characteristics of hepatoid and non‐hepatoid α‐fetoprotein‐producing gastric carcinomas: An experimental study using xenografted tumors , 1994, International journal of cancer.

[14]  H. Shima,et al.  [Adrenal hepatoid carcinoma producing alpha-fetoprotein: a case report]. , 1994, Hinyokika kiyo. Acta urologica Japonica.

[15]  J. Melamed,et al.  Hepatoid adenocarcinoma in the urinary bladder. Unusual localization of a newly recognized tumor type , 1994, Cancer.

[16]  T. Ulbright Germ Cell Neoplasms of the Testis , 1993, The American journal of surgical pathology.

[17]  W. Coleman,et al.  Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. , 1993, The American journal of pathology.

[18]  M. Tsuneyoshi,et al.  Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis , 1993, Cancer.

[19]  R. Keith,et al.  Hepatoid adenocarcinoma of the papilla of Vater , 1992, Histopathology.

[20]  T. Yoshiki,et al.  Hepatoid adenocarcinoma of the renal pelvis producing alpha‐fetoprotein of hepatic type and bile pigment , 1991, Cancer.

[21]  M. Shamoto,et al.  Hepatoid adenocarcinomas of the stomach: An analysis of seven cases , 1986, Cancer.

[22]  H. Ishikura,et al.  An AFP‐producing gastric carcinoma with features of hepatic differentiation. A case report , 1985, Cancer.

[23]  E. Ruoslahti,et al.  alpha-Fetoprotein in cancer and fetal development. , 1979, Advances in cancer research.

[24]  K. Sasajima,et al.  Precancerous changes in the stomach. , 1976, Cancer research.